1. Home
  2. VCIG vs EVOK Comparison

VCIG vs EVOK Comparison

Compare VCIG & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • EVOK
  • Stock Information
  • Founded
  • VCIG 2013
  • EVOK 2007
  • Country
  • VCIG Malaysia
  • EVOK United States
  • Employees
  • VCIG N/A
  • EVOK N/A
  • Industry
  • VCIG Diversified Commercial Services
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCIG Consumer Discretionary
  • EVOK Health Care
  • Exchange
  • VCIG Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • VCIG 23.8M
  • EVOK 7.4M
  • IPO Year
  • VCIG 2023
  • EVOK 2013
  • Fundamental
  • Price
  • VCIG $1.00
  • EVOK $4.94
  • Analyst Decision
  • VCIG
  • EVOK
  • Analyst Count
  • VCIG 0
  • EVOK 0
  • Target Price
  • VCIG N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • VCIG 3.6M
  • EVOK 11.7K
  • Earning Date
  • VCIG 02-11-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • VCIG 49.00%
  • EVOK N/A
  • EPS Growth
  • VCIG N/A
  • EVOK N/A
  • EPS
  • VCIG 7.82
  • EVOK N/A
  • Revenue
  • VCIG $23,548,256.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • VCIG N/A
  • EVOK $97.35
  • Revenue Next Year
  • VCIG N/A
  • EVOK $99.52
  • P/E Ratio
  • VCIG $0.13
  • EVOK N/A
  • Revenue Growth
  • VCIG 89.38
  • EVOK 100.35
  • 52 Week Low
  • VCIG $0.95
  • EVOK $3.54
  • 52 Week High
  • VCIG $103.39
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 35.67
  • EVOK 58.52
  • Support Level
  • VCIG $0.95
  • EVOK $4.22
  • Resistance Level
  • VCIG $1.15
  • EVOK $5.28
  • Average True Range (ATR)
  • VCIG 0.21
  • EVOK 0.31
  • MACD
  • VCIG -0.01
  • EVOK 0.06
  • Stochastic Oscillator
  • VCIG 6.67
  • EVOK 67.92

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: